Skip to content-
CancerLinQ Engages Leading Technology Companies Tempus and Precision HealthAI to Accelerate Data-Driven Insights to Oncologists and the Cancer Care Community
ALEXANDRIA, Va. — CancerLinQ LLC and the data services companies Tempus and Precision HealthAI announced today they have entered into an agreement that will accelerate development and delivery of [...]
-
Tempus Announces Latest Immunotherapy Project
CHICAGO, Nov. 15, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, [...]
-
Op-Ed: Enlisting Big Data in the War Against Cancer
To find cures for genomic disorders, using data, algorithms, cutting-edge analytics and software is imperative. By Eric Lefkofsky, Contributor |Nov. 1, 2017, at 12:58 p.m. The key to more personalized [...]
-
Putting Waste to Work
About a dozen years ago, my wife and I set up a family foundation. Generally, we were focused on supporting four causes that we felt needed more attention: education, human rights, civic causes and [...]
-
Lefkofsky startup takes on cancer
Eric Lefkofsky is bringing his genomics startup, Tempus, out of stealth mode, announcing today its first partnership, with Northwestern University’s cancer center. Several other hospital [...]
-
Groupon Cofounder’s New Healthcare Startup Raises $70 Million In Latest Funding Round
Published on Forbes.com September 25, 2017 Michela Tindera Billionaire Eric Lefkofsky built his fortune saving customers money on travel and restaurants with Groupon GRPN -0.59%. Now with his latest [...]
-
Tempus and the OHSU Knight Cancer Institute Collaborating on Personalized Medicine Data Initiative
CHICAGO, Sept. 28, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and [...]
-
Tempus and Cleveland Clinic Collaborate on Personalized Medicine Initiative
CHICAGO, Sept. 14, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and [...]
-
Tempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer Patients
CHICAGO, Aug. 31, 2017 (GLOBE NEWSWIRE) — Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data and [...]
-
Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium for Phase II Clinical Trial
Chicago, August 17 – Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data announced today that it [...]